In the following, we will summarize studies that have analyzed PCSK9 levels and lipoproteins in patients and experimental models suffering from metabolic disorders, including diabetes, obesity as well as inflammation and chronic liver injury. This evidence concerns the gene PCSK9 and obesity due to melanocortin 4 receptor deficiency.